好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Neurological Impairment and Disability in HTLV-1 Associated Myelopathy Patients
Infections/AIDS/Prion Disease
(-)
018
Authors/Disclosures
Francisco J. Carod-Artal, MD, FAAN (NHS Highlands) Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyers. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Dr. Carod-Artal has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Meyers Squip. Dr. Carod-Artal has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merz. Dr. Carod-Artal has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen. Dr. Carod-Artal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Narges Moghimi, MD (University of New Mexico) Dr. Moghimi has nothing to disclose.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file